We are live on ! Find out more
Raymond James Financial

Raymond James Financial Portfolio holdings

AUM $324B
1-Year Est. Return 22.36%
 

Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.

This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+22.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$290B
AUM Growth
+$24.8B
Cap. Flow
+$3.19B
Cap. Flow %
1.1%
Top 10 Hldgs %
21.85%
Holding
7,081
New
2,185
Increased
2,404
Reduced
2,172
Closed
80

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$962M
2
ABBV icon
AbbVie
ABBV
+$512M
3
BAC icon
Bank of America
BAC
+$172M
4
TJX icon
TJX Companies
TJX
+$157M
5
GEV icon
GE Vernova
GEV
+$156M

Sector Composition

Rank Sector Weight
1 Technology 16.54%
2 Financials 9.27%
3 Industrials 6.9%
4 Healthcare 6.27%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSX icon
6126
Diana Shipping
DSX
$299M
$4.96K ﹤0.01%
+3,398
New +$5.11K
UMMA icon
6127
Wahed Dow Jones Islamic World ETF
UMMA
$292M
$4.96K ﹤0.01%
+186
New +$4.61K
FBCV
6128
Fidelity Blue Chip Value ETF
FBCV
$183M
$4.94K ﹤0.01%
+151
New +$4.77K
NEOV icon
6129
NeoVolta
NEOV
$148M
$4.92K ﹤0.01%
+1,490
New +$4.27K
USNA icon
6130
Usana Health Sciences
USNA
$261M
$4.92K ﹤0.01%
+161
New +$4.57K
XRLV
6131
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
$4.9K ﹤0.01%
89
-5,037
-98% -$276K
VIVS
6132
VivoSim Labs
VIVS
$1.27M
$4.87K ﹤0.01%
+3,313
New +$6.07K
VET icon
6133
Vermilion Energy
VET
$1.74B
$4.84K ﹤0.01%
+665
New +$4.54K
IMVT icon
6134
Immunovant
IMVT
$8.19B
$4.8K ﹤0.01%
300
-59,374
-99% -$898K
STLN
6135
Starling Oncology, Inc. Common Stock
STLN
$644M
$4.78K ﹤0.01%
+2,331
New +$5.83K
GYRE icon
6136
Gyre Therapeutics
GYRE
$710M
$4.78K ﹤0.01%
+650
New +$5.67K
ARQ icon
6137
Arq
ARQ
$97M
$4.77K ﹤0.01%
+888
New +$3.89K
GORO icon
6138
Goldgroup Mining Inc.
GORO
$185M
$4.76K ﹤0.01%
+7,804
New +$4.25K
SCHL icon
6139
Scholastic
SCHL
$783M
$4.74K ﹤0.01%
+226
New +$4.12K
LAB icon
6140
Standard BioTools
LAB
$312M
$4.66K ﹤0.01%
+3,881
New +$4.3K
OMAB icon
6141
Grupo Aeroportuario Centro Norte
OMAB
$5.19B
$4.64K ﹤0.01%
+44
New +$4.13K
TKC icon
6142
Turkcell
TKC
$4.74B
$4.57K ﹤0.01%
+756
New +$4.59K
OTLK icon
6143
Outlook Therapeutics
OTLK
$208M
$4.56K ﹤0.01%
+2,851
New +$4.54K
AIRT icon
6144
Air T
AIRT
$82.8M
$4.53K ﹤0.01%
+206
New +$3.67K
ASMB icon
6145
Assembly Biosciences
ASMB
$526M
$4.53K ﹤0.01%
+250
New +$3.3K
SPRU icon
6146
Spruce Power Holding Corp
SPRU
$41M
$4.52K ﹤0.01%
+2,237
New +$4.37K
ITRM
6147
DELISTED
Iterum Therapeutics
ITRM
$4.49K ﹤0.01%
+4,513
New +$4.71K
RMR icon
6148
The RMR Group
RMR
$338M
$4.47K ﹤0.01%
+274
New +$4.2K
VRCA icon
6149
Verrica Pharmaceuticals
VRCA
$92.9M
$4.45K ﹤0.01%
+840
New +$4.52K
SHAG icon
6150
WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund
SHAG
$47.3M
$4.45K ﹤0.01%
+93
New +$4.43K

Similar funds

Raymond James Financial's Q2 2025 Portfolio in Review

As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James Financial's Q2 2025 filing shows 2,185 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
  • Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
  • Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
  • Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
  • Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
  • Raymond James Financial opened 2,185 new positions and closed 80 in Q2 2025.
  • Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.

Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.